Exploring the Synergistic Action of Medium-Chain Triglycerides and Omega-3 Fatty Acids to Enhance Cellular Uptake and Anti-Inflammatory Responses

被引:0
作者
Isern, Camila Kaminskas Fernandes [1 ]
Chen, Yao [1 ]
Touboul, Roni [1 ]
Frank, Benjamin [1 ]
Hu, Shuchen [1 ]
Chang, Chuchun L. [1 ,2 ]
机构
[1] Columbia Univ, Inst Human Nutr, Vagelos Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pediat, Div Gastroenterol Hepatol & Nutr, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
fatty acids; inflammation; immune response; MCT; omega-3; LIPOPROTEIN-LIPASE DEFICIENCY; INTRAVENOUS LIPID EMULSIONS; FATTY-ACIDS; BLOOD CLEARANCE; IN-VIVO; PARTICLE-SIZE; LONG-CHAIN; PARENTERAL-NUTRITION; ACUTE-INFLAMMATION; APOLIPOPROTEIN-E;
D O I
10.3390/nu17111889
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objectives: Omega-3 fatty acids (n-3 FA) exhibit pro-healing and anti-inflammatory properties. Injectable lipid emulsions containing n-3 FA are being explored for the treatment of acute adverse conditions. Our previous studies demonstrated that a triglyceride (TG)-rich emulsion (TGRP) containing medium-chain TG (MCT) and n-3 TG (8:2 ratio) is rapidly cleared from the blood and efficiently taken up by organs. This study systematically examined the impact of varying MCT:n-3 ratios on cellular uptake and metabolic function in inflammatory processes. Methods and results: We measured the uptake of radio-labeled TGRP, comprising pure MCT, n-3, or mixed at selected ratios (8:2, 6:4, 2:8), both in vitro and in vivo. Murine macrophages with MCT:n-3 (6:4 or 2:8) had a 2-fold higher TG uptake. IV-injected mixed TGRP also enhanced blood clearance and organ uptake. n-3 TGRP reduced LPS-induced pro-inflammatory cytokines (TNF-alpha, IL-1, IL-6) in a dose-dependent manner. The 8:2 ratio enhanced mitochondrial respiration and glycolytic capacity in macrophages. Pro-inflammatory lipids decreased with MCT:n-3 (2:8) and pure n-3 TGRP. Bolus injections of n-3 TGRP with MCT lowered LPS-induced IL-6 in plasma and tissues. Conclusions: MCT and n-3 FA support metabolic activity and exhibit anti-inflammatory effects, suggesting that optimizing their ratio may enhance the therapeutic effects of emulsions for inflammatory conditions.
引用
收藏
页数:27
相关论文
共 92 条
[1]   Assessing mitochondrial respiratory bioenergetics in whole cells and isolated organelles by microplate respirometry [J].
Agrawal, Rishi R. ;
Tamucci, Kirstin A. ;
Pera, Marta ;
Larrea, Delfina .
MITOCHONDRIA, 3RD EDITION, 2020, 155 :157-180
[2]   Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: A major pathway at physiological particle concentrations [J].
AlHaideri, M ;
Goldberg, IJ ;
Galeano, NF ;
Gleeson, A ;
Vogel, T ;
Gorecki, M ;
Sturley, SL ;
Deckelbaum, RJ .
BIOCHEMISTRY, 1997, 36 (42) :12766-12772
[3]   Adaptive mechanisms regulate preferred utilization of ketones in the heart and brain of a hibernating mammal during arousal from torpor [J].
Andrews, Matthew T. ;
Russeth, Kevin P. ;
Drewes, Lester R. ;
Henry, Pierre-Gilles .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2009, 296 (02) :R383-R393
[4]   Lipids in Parenteral Nutrition: Biological Aspects [J].
Calder, Philip C. ;
Waitzberg, Dan L. ;
Klek, Stanislaw ;
Martindale, Robert G. .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2020, 44 :S21-S27
[5]   Intravenous Lipid Emulsions to Deliver Bioactive Omega-3 Fatty Acids for Improved Patient Outcomes [J].
Calder, Philip C. .
MARINE DRUGS, 2019, 17 (05)
[6]   The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability [J].
Calder, Philip C. .
MOLECULAR NUTRITION & FOOD RESEARCH, 2012, 56 (07) :1073-1080
[7]   n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases [J].
Calder, Philip C. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) :1505S-1519S
[8]   Intravenous lipid emulsions to deliver omega 3 fatty acids [J].
Carpentier, Y. A. ;
Hacquebard, M. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (03) :145-148
[9]  
CARPENTIER YA, 1986, INFUS KLIN ERN, V13, P182
[10]  
Carpentier YA, 2006, INT J MOL MED, V17, P643